SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Brain Nerve Stimulation Could Speed Up Learning, University of Texas Study Suggests
April 14, 2011
 · 
1 min read
Lone Star Bio
Is Alcoholism a Learning Disorder? – University of Texas Study
April 14, 2011
 · 
1 min read
Lone Star Bio
‘Ricewrist’ Robot Helps Spinal-Cord Injury Victim, Rice University Reveals
April 13, 2011
 · 
1 min read
Lone Star Bio
Alcohol Helps the Brain Remember, Says New University of Texas Study
April 12, 2011
 · 
1 min read
Lone Star Bio
‘Good Cholesterol’ Nanoparticles Seek and Destroy Cancer Cells, University of Texas MD Anderson Cancer Center Reveals
April 12, 2011
 · 
1 min read
Lone Star Bio
Blueberries May Inhibit Development of Fat Cells, Texas Woman’s University Study
April 11, 2011
 · 
1 min read
Lone Star Bio
Dangerous Blood Pressure Increases During Exercise Can be Blocked, UT Southwestern Medical Center Study
April 5, 2011
 · 
1 min read
Lone Star Bio
Potential New Non-Insulin Treatment for Type 1 Diabetes Found, UT Southwestern Medical Center Study Reveals
March 25, 2011
 · 
3 min read
Lone Star Bio
Nanomaterial Bulks Up Under Stress, Rice University Study Reveals
March 24, 2011
 · 
1 min read
Lone Star Bio
Menthol Cigarette Less Likely to Cause Lung Cancer? - Vanderbilt University and Meharry Medical College Study Reveals
March 24, 2011
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 28, 2026
 · 
5 min read
Press Releases
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 26, 2026
 · 
6 min read
Press Releases
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
June 26, 2026
 · 
11 min read
Press Releases
DecisionDx®-Melanoma’s i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy
June 25, 2026
 · 
10 min read
Press Releases
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
June 25, 2026
 · 
7 min read
Press Releases
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
June 25, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
June 25, 2026
 · 
3 min read
Press Releases
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
June 25, 2026
 · 
5 min read
Press Releases
Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026
June 24, 2026
 · 
5 min read
Press Releases
Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
June 24, 2026
 · 
5 min read
Load More